Laboratoire Français du Fractionnement et des Biotechnologies
发明人:
Abdessatar Sami Chtourou
申请号：
US15319178
公开号：
US20170121402A1
申请日:
2015.06.18
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical composition for oral delivery, including an anti tumour necrosis factor alpha (TNFα) antibody, preferably a monoclonal antibody produced in the milk of a transgenic non-human animal, and which can be combined advantageously with caprylic acid, and is preferably in a form that is suitable for targeted release of the antibody in the intestine.
